Similarly, the treatment of human esophageal adenocarcinoma cells with sPLA2 inhibitor attenuates the expression of ICAM-1 [173] and decreases viability and proliferation of this type of cancer cell [174]. The gene discussed is ICAM1; the disease is cancer.